Trials / Unknown
UnknownNCT03564002
Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- University Of Perugia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The very low carbohydrates diet (VLCKD) induces liver steatosis amelioration. Lysosomal acid lipase (LAL) deficiency plays a role in fats accumulation in liver. To date, no studies have assessed LAL activity in morbid obesity. The aim of our study is to evaluate VLCKD impact on metabolic/vascular parameters and LAL activity in obese patients. A VLCKD is administered for 25 days to 52 morbid obese patients (BMI 44.7±8.3 kg/m², age 49±12.5 years); at baseline and after diet we evaluated: BMI, glyco-lipidic pattern, abdominal ultrasonography (liver steatosis and visceral fat area) and flow-mediated dilation (FMD). In a subgroup of 20 patients we also tested lysosomal acid lipase (LAL)-activity. A group of healthy normal weight subjects (age 43±13, BMI 22.8±2.6 kg/m²) was also included in the study.
Conditions
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2018-06-20
- Last updated
- 2020-03-09
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03564002. Inclusion in this directory is not an endorsement.